-
Are zoos ethical?
The Explainer Examining the pros and cons of supporting these controversial institutions
The Explainer -
Is the economy headed for a 'soft landing'?
The Explainer The outlook is improving as inflation falls. Is a recession becoming less likely?
The Explainer -
The pros and cons of noncompete agreements
The Explainer The FTC wants to ban companies from binding their employees with noncompete agreements. Who would this benefit, and who would it hurt?
The Explainer -
How Russia's Iranian arms deals in Ukraine are scrambling alliances in the Middle East
The Explainer Where Syria, Iran, Saudi Arabia, Israel, and Turkey now stand
The Explainer -
Welcome to the new TheWeek.com!
The Explainer Please allow us to reintroduce ourselves
The Explainer -
What experts are saying about the economy's surprise contraction
The Explainer The sharpest opinions on the debate from around the web
The Explainer -
How do you solve a problem like Facebook?
The Explainer The social media giant is under intense scrutiny. But can it be reined in?
The Explainer -
Do unvaccinated COVID patients deserve scarce care? A doctor weighs in.
The Explainer Justice, judgment, and the last ICU bed
The Explainer -
The Oscars finale was a heartless disaster
The Explainer A calculated attempt at emotional manipulation goes very wrong
The Explainer -
The death of cities was greatly exaggerated
The Explainer Why the pandemic predictions about urban flight were wrong
The Explainer -
How to vaccinate the anti-vaxxers
The Explainer Instead of blaming people for not doing the right thing, let's focus on eliminating the obstacles to vaccination that still remain
The Explainer -
Will COVID-19 wind up saving lives?
The Explainer By spurring vaccine development, the pandemic is one crisis that hasn’t gone to waste
The Explainer -
Most awkward awards show ever?
The Explainer The best, worst, and most shocking moments from a chaotic Golden Globes
The Explainer -
The U.S. could double its COVID-19 vaccine availability overnight. What's the holdup?
The Explainer How the FDA could approve a more efficient vaccine rollout
The Explainer
